The AXIN2 rs3923087, DKK3 rs6485350 and the SFRP3 rs7775 that was significantly associated with decreased risk of breast cancer in the overall study population also exhibited significant protection for the ER + as well as ER- group (Tables 5 and 6). This evidence concerns the gene ESR1 and breast carcinoma.